Revolution Medicines Inc
RVMD
Market Cap$6.16B
Close$
$4.92
86.3% downside
Current Fair Value
86.3% downsideOvervalued by 86.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.16 Billion |
|---|---|
| Enterprise Value | $4.40 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.86 |
| Beta | 1.25 |
| Outstanding Shares | 164,690,000 |
| Avg 30 Day Volume | 1,678,227 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -14.12 |
|---|---|
| PEG | -7.6 |
| Price to Sales | - |
| Price to Book Ratio | 3.26 |
| Enterprise Value to Revenue | 379.62 |
| Enterprise Value to EBIT | -9.02 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
ESG Score
No data
About Revolution Medicines Inc
CEO: Mark Goldsmith